nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A novel 5’ALK fusion identified by next generation sequencing and validated by IHC in a patient with lung adenocarcinoma
|
He, Zhengfu |
|
|
158 |
C |
p. 164-165 |
artikel |
2 |
A Novel Nonreciprocal/Reciprocal ALK Translocation Cause ALK+ in NSCLC
|
Chen, Xianguo |
|
|
158 |
C |
p. 162-163 |
artikel |
3 |
Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trial
|
Lavole, Armelle |
|
|
158 |
C |
p. 146-150 |
artikel |
4 |
Baseline and early changes in circulating Serum Amyloid A (SAA) predict survival outcomes in advanced non-small cell lung cancer patients treated with Anti-PD-1/PD-L1 monotherapy
|
He, Li-Na |
|
|
158 |
C |
p. 1-8 |
artikel |
5 |
Contents
|
|
|
|
158 |
C |
p. v-vi |
artikel |
6 |
Corrigendum to “A phase 2 study of tislelizumab in combination with platinum-based chemotherapy as first-line treatment for advanced lung cancer in Chinese patients” [Lung Cancer 147 (2020) 259–268]
|
Wang, Zhijie |
|
|
158 |
C |
p. 166-167 |
artikel |
7 |
Durable response to serial tyrosine kinase inhibitors (TKIs) in an adolescent with metastatic TFG-ROS1 fusion positive Inflammatory Myofibroblastic Tumor (IMT)
|
Ingley, Katrina M. |
|
|
158 |
C |
p. 151-155 |
artikel |
8 |
Durvalumab consolidation therapy in a patient with stage IIIB unresectable NSCLC harboring a MET exon 14 splice site alteration
|
Cytryn, Samuel |
|
|
158 |
C |
p. 15-17 |
artikel |
9 |
Editorial Board
|
|
|
|
158 |
C |
p. iii |
artikel |
10 |
Effectiveness and safety of immunotherapy in NSCLC patients with ECOG PS score ≥2 – Systematic review and meta-analysis
|
Tomasik, Bartłomiej |
|
|
158 |
C |
p. 97-106 |
artikel |
11 |
Efficacy and safety of treatment modalities across EGFR selected/unselected populations with non-small cell lung cancer and brain metastases: A systematic review and Bayesian network meta-analysis
|
Liu, Lihui |
|
|
158 |
C |
p. 74-84 |
artikel |
12 |
Endobronchial ultrasound for T4 staging in patients with resectable NSCLC
|
Kuijvenhoven, Jolanda C. |
|
|
158 |
C |
p. 18-24 |
artikel |
13 |
Going beneath the tip of the iceberg. Identifying and understanding EML4-ALK variants and TP53 mutations to optimize treatment of ALK fusion positive (ALK+) NSCLC
|
Zhang, Shannon S. |
|
|
158 |
C |
p. 126-136 |
artikel |
14 |
Incidence of tuberculosis in advanced lung cancer patients treated with immune checkpoint inhibitors – A nationwide population-based cohort study
|
Kim, Hyung Woo |
|
|
158 |
C |
p. 107-114 |
artikel |
15 |
Integrative analyses identified ion channel genes GJB2 and SCNN1B as prognostic biomarkers and therapeutic targets for lung adenocarcinoma
|
Lu, Ao |
|
|
158 |
C |
p. 29-39 |
artikel |
16 |
Multi-disciplinary approach for the management of non-metastatic non-small cell lung cancer in the Middle East and Africa: Expert panel recommendations
|
Göker, Erdem |
|
|
158 |
C |
p. 60-73 |
artikel |
17 |
NRG1 fusions: Biology to therapy
|
Liu, Stephen V. |
|
|
158 |
C |
p. 25-28 |
artikel |
18 |
Performance of the EarlyCDT® Lung test in detection of lung cancer and pulmonary metastases in a high-risk cohort
|
Borg, Morten |
|
|
158 |
C |
p. 85-90 |
artikel |
19 |
Predictive markers based on transcriptome modules for vinorelbine-based adjuvant chemotherapy for lung adenocarcinoma patients
|
Nakasone, Shoko |
|
|
158 |
C |
p. 115-125 |
artikel |
20 |
Prognostic value of PET parameters in patients with pleomorphic lung cancer: Results from a single institution
|
Di Stasio, G.D. |
|
|
158 |
C |
p. 40-46 |
artikel |
21 |
Quantification of HER family dimers by proximity ligation assay and its clinical evaluation in non–small cell lung cancer patients treated with osimertinib
|
Liu, Renpeng |
|
|
158 |
C |
p. 156-161 |
artikel |
22 |
Survival benefit of osimertinib combination therapy in patients with T790M-positive non-small-cell lung cancer refractory to osimertinib treatment
|
Su, Po-Lan |
|
|
158 |
C |
p. 137-145 |
artikel |
23 |
The impact of pathological lymph node metastasis with lymphatic invasion on the survival of patients with clinically node-negative non-small cell lung cancer: A multicenter study
|
Sato, Tomo |
|
|
158 |
C |
p. 9-14 |
artikel |
24 |
The modification of T description according to visceral pleural invasion and tumor size from 3.1 cm to 4.0 cm in non-small cell lung cancer: A retrospective analysis based on the SEER database
|
Qi, Mengfan |
|
|
158 |
C |
p. 47-54 |
artikel |
25 |
Thoracic NUT carcinoma: Common pathological features despite diversity of clinical presentations
|
Fekkar, Amal |
|
|
158 |
C |
p. 55-59 |
artikel |
26 |
Tumor-associated macrophage infiltration is associated with a higher rate of tumor spread through air spaces in resected lung adenocarcinomas
|
Yoshida, Chihiro |
|
|
158 |
C |
p. 91-96 |
artikel |